The regulatory landscape for actively personalized cancer immunotherapies

Cedrik M. Britten; Harpreet Singh-Jasuja; Bruno Flamion; Axel Hoos; Christoph Huber; Karl Josef Kallen; Samir N. Khleif; Sebastian Kreiter; Michaela Nielsen; Hans Georg Rammensee; Ugur Sahin; Thomas Hinz; Ulrich Kalinke

doi:10.1038/nbt.2708

The regulatory landscape for actively personalized cancer immunotherapies

Cedrik M. Britten, Harpreet Singh-Jasuja, Bruno Flamion, Axel Hoos, Christoph Huber, Karl Josef Kallen, Samir N. Khleif, Sebastian Kreiter, Michaela Nielsen, Hans Georg Rammensee, Ugur Sahin, Thomas Hinz, Ulrich Kalinke

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	880-882
Number of pages	3
Journal	Nature Biotechnology
Volume	31
Issue number	10
DOIs	https://doi.org/10.1038/nbt.2708
Publication status	Published - 1 Oct 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nbt.2708

Cite this

@article{4acd75d517c44eb889f35bf75988167e,

title = "The regulatory landscape for actively personalized cancer immunotherapies",

author = "Britten, {Cedrik M.} and Harpreet Singh-Jasuja and Bruno Flamion and Axel Hoos and Christoph Huber and Kallen, {Karl Josef} and Khleif, {Samir N.} and Sebastian Kreiter and Michaela Nielsen and Rammensee, {Hans Georg} and Ugur Sahin and Thomas Hinz and Ulrich Kalinke",

year = "2013",

month = oct,

day = "1",

doi = "10.1038/nbt.2708",

language = "English",

volume = "31",

pages = "880--882",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - The regulatory landscape for actively personalized cancer immunotherapies

AU - Britten, Cedrik M.

AU - Singh-Jasuja, Harpreet

AU - Flamion, Bruno

AU - Hoos, Axel

AU - Huber, Christoph

AU - Kallen, Karl Josef

AU - Khleif, Samir N.

AU - Kreiter, Sebastian

AU - Nielsen, Michaela

AU - Rammensee, Hans Georg

AU - Sahin, Ugur

AU - Hinz, Thomas

AU - Kalinke, Ulrich

PY - 2013/10/1

Y1 - 2013/10/1

UR - http://www.scopus.com/inward/record.url?scp=84885659334&partnerID=8YFLogxK

U2 - 10.1038/nbt.2708

DO - 10.1038/nbt.2708

M3 - Article

AN - SCOPUS:84885659334

SN - 1087-0156

VL - 31

SP - 880

EP - 882

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 10

ER -

The regulatory landscape for actively personalized cancer immunotherapies

UN SDGs

Access to Document

Other files and links

Cite this